Related Experiment Video
Updated: Mar 12, 2026

Rectal Organoid Morphology Analysis ROMA: A Diagnostic Assay in Cystic Fibrosis
Published on: June 10, 2022
Executive function in pediatric patients with cystic fibrosis, inflammatory bowel disease and in healthy controls
B Piasecki1, R Turska-Malińska, T Matthews-Brzozowska
1Department of Clinical Psychology, Poznan University of Medical Sciences, Poznan, Poland. bpiasecki@ump.edu.pl.
Insights
Pediatric patients with cystic fibrosis (CF) show executive function deficits compared to healthy children and those with inflammatory bowel disease (IBD). This study is the first to report these CF-related cognitive impairments.
Area of Science:
- Neuroscience
- Pediatric Medicine
- Psychology
Background:
- Executive function is crucial for daily activities.
- Pediatric chronic illnesses like cystic fibrosis (CF) and inflammatory bowel disease (IBD) may impact cognitive development.
- Limited research exists on executive function in pediatric CF and IBD populations.
Purpose of the Study:
- To compare executive function performance in children with CF, IBD, and healthy controls.
- To identify potential cognitive deficits associated with CF and IBD in pediatric patients.
- To establish a baseline for cognitive functioning in these patient groups.
Main Methods:
- The study included 28 pediatric patients with CF, 30 with IBD, and 30 healthy controls (ages 7-17).
- All participants were within the intellectual norm range.
- Executive functions were assessed using the Wisconsin Card Sorting Test (WCST).
Main Results:
- Pediatric patients with CF demonstrated significantly poorer performance on multiple WCST indicators compared to both healthy controls and IBD patients (p < 0.05).
- Specific deficits in CF patients included more errors, fewer conceptual level responses, and longer time to complete categories.
- No significant executive function differences were found between the IBD group and the healthy control group.
Conclusions:
- This study provides the first evidence of executive function deficits in pediatric patients with cystic fibrosis.
- It also presents the initial description of executive function performance in pediatric IBD patients.
- The findings highlight the need for cognitive assessment and support in children with CF.
Objective:
The main aim of this study was to analyze and compare executive function performance in pediatric patients with cystic fibrosis (CF), inflammatory bowel disease (IBD) and in healthy controls.
Patients And Methods:
28 patients with CF, 30 patients with IBD and 30 healthy participants took part in the study (all in the age range of 7-17). All participants were in the intellectual norm. The Wisconsin Card Sorting Test (WCST) was applied to assess executive functions.
Results:
The CF group received significantly (p < 0.05) poorer scores than the control and IBD groups in the following WCST indicators: Number of trials administered, Total number of errors, Perseverative errors, Non-perseverative errors, Percent of conceptual level responses, Trials to complete the first category. The IBD group was not significantly different from the control group in any of the WCST indicators.
Conclusions:
To our best knowledge, results of this study are the first report of the presence of executive function deficits among pediatric patients with CF. It is also the first study that describes the performance of the executive function in IBD pediatric patients, and the first that compares cognitive functioning between CF and IBD patients.
More Related Videos
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
10:02Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
Published on: March 12, 2020
Related Concept Videos
Cystic Fibrosis: Management
Sinus disease and chronic...
Information Processing Approach
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Role of Cerebellum and Prefrontal Cortex in Memory